Correlation Between SAB Biotherapeutics and Organon
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Organon Co, you can compare the effects of market volatilities on SAB Biotherapeutics and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Organon.
Diversification Opportunities for SAB Biotherapeutics and Organon
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between SAB and Organon is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Organon go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Organon
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 43.3 times more return on investment than Organon. However, SAB Biotherapeutics is 43.3 times more volatile than Organon Co. It trades about 0.11 of its potential returns per unit of risk. Organon Co is currently generating about -0.02 per unit of risk. If you would invest 4.04 in SAB Biotherapeutics on August 27, 2024 and sell it today you would earn a total of 3.26 from holding SAB Biotherapeutics or generate 80.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 75.4% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Organon Co
Performance |
| Timeline |
| SAB Biotherapeutics |
| Organon |
SAB Biotherapeutics and Organon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Organon
The main advantage of trading using opposite SAB Biotherapeutics and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
| Organon vs. Johnson Johnson | Organon vs. Bristol Myers Squibb | Organon vs. AbbVie Inc | Organon vs. Eli Lilly and |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |